OROV (Oropouche virus) recombinant proteins are synthetic versions of viral proteins produced using recombinant DNA technology. Oropouche virus is an arbovirus belonging to the Peribunyaviridae family, causing Oropouche fever, a significant public health concern in parts of Central and South America. OROV recombinant proteins are essential tools for studying the virus’s biology, developing diagnostic tools, and advancing vaccine research.

Content

Structure and Function
  • OROV has a tripartite RNA genome encoding three main segments: L (large), M (medium), and S (small), which code for structural and non-structural proteins.
  • Recombinant proteins often include the Nucleocapsid (N) protein, Glycoproteins (Gn and Gc), and NSs protein, which are critical for virus assembly, entry, and immune evasion.
  • These proteins are used to study viral replication, immune responses, and host-virus interactions.

Production
  • OROV recombinant proteins are typically produced in expression systems like E. coli, insect cells (baculovirus system), or mammalian cells, depending on the desired post-translational modifications and folding.
  • Purification involves affinity chromatography techniques, leveraging tags (e.g., His-tag) or specific antibody-based methods for isolation of the recombinant proteins.

Applications
  • Diagnostic Development: Recombinant OROV proteins are used to develop ELISA assays for the detection of Oropouche virus-specific antibodies in patient sera, aiding in diagnosis.
  • Vaccine Research: These proteins are critical in the development of subunit vaccines by inducing immune responses without the need for live virus.
  • Basic Research: They help in studying viral entry, replication, and pathogenesis, and in screening antiviral compounds targeting specific viral proteins.

Validation and Quality Control
  • Rigorous validation processes ensure that recombinant OROV proteins are correctly folded, active, and free from contaminants.
  • Techniques like SDS-PAGE, Western blotting, and functional assays (e.g., binding to specific antibodies or receptor proteins) are employed to confirm the identity and functionality of the proteins.
AffiREC® Oropouche Virus Gc Protein, Human Fc
CAT# AFG-NTG-0288
Size: 0.5 mg
1,260.87 1260.8700000000001 USD
AffiREC® Oropouche Virus Gc Protein, Human Fc
CAT# AFG-NTG-0287
Size: 0.1 mg
364.61 364.61 USD
AffiREC® Oropouche Virus Gn Protein, Human Fc
CAT# AFG-NTG-0271
Size: 0.5 mg
2,067.34 2067.34 USD
AffiREC® Oropouche Virus Gn Protein, Human Fc
CAT# AFG-NTG-0270
Size: 0.1 mg
527.70 527.7 USD
AffiREC® Oropouche Virus Gn Protein, Mouse Fc
CAT# AFG-NTG-0269
Size: 0.5 mg
1,798.02 1798.02 USD
AffiREC® Oropouche Virus Gn Protein, Mouse Fc
CAT# AFG-NTG-0268
Size: 0.1 mg
455.88 455.88 USD
AffiREC® Oropouche Virus Gc Protein, Mouse Fc
CAT# AFG-NTG-0261
Size: 0.5 mg
2,157.12 2157.12 USD
AffiREC® Oropouche Virus Gc Protein, Mouse Fc
CAT# AFG-NTG-0260
Size: 0.1 mg
545.66 545.66 USD
AffiREC® Oropouche Virus Nucleoprotein
CAT# AFG-NTG-0255
Size: 0.5 mg
1,040.92 1040.92 USD
AffiREC® Oropouche Virus Nucleoprotein
CAT# AFG-NTG-0254
Size: 0.1 mg
306.26 306.26 USD